|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.8 JOD | +1.45% |
|
-.--% | -.--% |
Beit Jala Pharmaceutical Company reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JOD 9.61 million compared to JOD 10.77 million a year ago. Net income was JOD 1.84 million compared to JOD 1.98 million a year ago.
Basic earnings per share from continuing operations was JOD 0.262 compared to JOD 0.283 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 27.65M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
BEIT JALA PHARMACEUTICAL COMPANY 
